Unlocking Antioxidant–Anticancer Synergy: An Exploration of Therapeutic Bioactives from Methanolic Extracts of Rubus ellipticus and Boerhavia diffusa Using HeLa Cell Line
ASSAY and Drug Development Technologies · 2024
DOI: 10.1089/adt.2024.040 ↗Kurz gefasst
Fachartikel in der Zeitschrift ASSAY and Drug Development Technologies, 2024. Verfasst von Vipresh Bhardwaj und 2 weiteren Autor:innen. Beteiligte Einrichtung: Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India. Hauptthemen laut MEDLINE: Plant Extracts, Antioxidants, Antineoplastic Agents, Phytogenic, Nyctaginaceae. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 29 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Amity Institute of Pharmacy, Amity University, Noida, Uttar Pradesh, India.
- Gokaraju Rangaraju College of Pharmacy, Hyderabad, Telangana, India.
- School of Pharmaceutical and Public Health Informatics DIT University Dehradun Uttarakhand, India 248009.
ORCID-Profile: G T Kulkarni, Kalpana Nagpal
Zitieren
APA
Bhardwaj, V., Kulkarni, G. T., & Nagpal, K. (2024). Unlocking Antioxidant–Anticancer Synergy: An Exploration of Therapeutic Bioactives from Methanolic Extracts of Rubus ellipticus and Boerhavia diffusa Using HeLa Cell Line. ASSAY and Drug Development Technologies. https://doi.org/10.1089/adt.2024.040
Vancouver
Bhardwaj V, Kulkarni GT, Nagpal K. Unlocking Antioxidant–Anticancer Synergy: An Exploration of Therapeutic Bioactives from Methanolic Extracts of Rubus ellipticus and Boerhavia diffusa Using HeLa Cell Line. ASSAY and Drug Development Technologies. 2024. doi:10.1089/adt.2024.040
BibTeX
@article{Bhardwaj2024,
author = {Bhardwaj, Vipresh and Kulkarni, G T and Nagpal, Kalpana},
title = {Unlocking Antioxidant–Anticancer Synergy: An Exploration of Therapeutic Bioactives from Methanolic Extracts of Rubus ellipticus and Boerhavia diffusa Using HeLa Cell Line},
journal = {ASSAY and Drug Development Technologies},
year = {2024},
doi = {10.1089/adt.2024.040}
}
EUVIMED